申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0402097A1
公开(公告)日:1990-12-12
A class of halogen-substituted diphenylsulfide compounds are disclosed which produce a large selective inhibition of serotonin reuptake in brain.
Such compounds are useful in the treatment or prevention of a range of depressive conditions as well as anxiety, obsessive compulsive disorders and alcoholism.
本研究公开了一类卤素取代的二苯基硫化合物,它们能对大脑中的血清素再摄取产生较大的选择性抑制作用。
这类化合物可用于治疗或预防一系列抑郁症、焦虑症、强迫症和酗酒。